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Abstract 
Introduction: Depressive disorders increase the risks of self-harm or even suicide in 
patients. Indigenous drugs are being tried to treat such patient along with conventional 
antidepressant drugs.  
Objective: To investigate the antidepressant action of Ashwagandha and Bramhi and also to 
confirm its efficacy in the behavioral despair animal model of depression.  
Material and methods: Normal saline as control (5ml/kg), imipramine as standard (16,32,64 
mg/kg) and ashwagandha (50,100,150 mg/kg), bramhi (20,40,80 mg/kg) as test drugs were 
introduced to the albino rats weighing between 200-250gm for 2 weeks, 1 hr before electric 
shock in Learned helplessness test (LHT) and swimming in Forced swimming test (FST). 
Effects of individual drugs as well as their combination were evaluated. 
Result: Avoidance response, escape failure and immobility period in case of imipramine and 
ashwagandha showed highly significant (p<0.01) result on individual use.  There was no 
significant result in case of Bramhi used alone except in escape failure and immobility period 
(FST), where at higher doses it showed significant (p<0.01) result . But combination of 
Bramhi and ashwagandha in low doses with low dose of imipramine gave a highly significant 
result (p<0.01) in all the parameters. 
Conclusion: Ashwagandha had significant antidepressant action, but bramhi had not when 
used alone. Combination of these two indigenous drugs with imipramine showed high 
efficacy in animal model. 
Key Words: Ashwagandha, Bramhi, Forced swimming test, Indigenous drug, learned 
helplessness test. 
Key massages: Ashwagandha and bramhi showed high efficacy in depression model when 
combine with low dose imipramine. So these drugs may be tried in the treatment of 
depression and further scientific research should be under taken for cost effectiveness and 
reduce the adverse effect of modern therapy. 
 
Introduction:  
Depression is a heterogeneous 
disorder that affects a person’s mood, 
physical health and behaviour. Incidence 
of depressive mood disorders is rising in 
the modern stressful society leading to 
increased risks of self-harm or suicide as 
well as increased mortality from related 
general medical conditions.(1) As many as 
10-15% of individuals with this disorder 
exhibit suicidal tendency during their life 
time. These groups of patients respond 
well to anti depressant drugs and in severe 
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cases to ECT (Electro Convulsive 
Therapy). 
Treatments of major mood 
disorders have improved in recent years 
with the advent of newer antidepressant 
drugs like TCAs (Imipramine), SSRIs 
(Fluoxetine), MAO-Is and atypical 
antidepressants, which are more selective 
with insignificant side effects. Generally 
the antidepressant agents are reserved for 
severe & otherwise incapacitating 
depressive disorders.(2) Though they are 
effective they are not totally devoid of side 
effects & relatively expensive for long-
term use. Therefore evaluation of natural 
products for the management of major 
mood disorders was justified. Research 
trials are continuing to introduce numerous 
herbal formulation approved by food and 
drug administration for the treatment of 
several psychological conditions.(3) 
Ashwagandha (Withania somnifera), 
bramhi (Bacopa monniera) have memory 
enhancing and anxiolytic effect along with 
improvement of cognitive function(4) But 
data relating to their antidepressant action 
is yet to be established. Therefore it was 
justified to investigate the antidepressant 
action of ashwagandha and bramhi in this 
present study.  
Study aim was to investigate the 
antidepressant actions of ashwagandha and 
bramhi in behavioural despair animal 
model of depression for confirmation of 
the already reported efficacy.  
 
Material & Methods 
Learned helplessness test (LHT)(5)
 
and Forced swimming test (FST)(6) 
models were used for preparation of 
behavioral despair animal model. Albino 
rats weighing between 200-250gm were 
allowed free access to food and water 
adlibitum and were maintained under 
standard laboratory conditions with a 
natural light and dark cycle following 
CPCSEA (Committee For The Purpose Of 
Control and Supervision on Experiments 
on Animals) guidelines. The animals were 
acclimatized for 5 days before behavioral 
experiments which were carried out 
between 09.00 A.M and 1.00 P.M. 
 
Apparatus  
1. Gemini Avoidance System: This 
apparatus is divided into two equal 
compartments by a retractable 
door. Floors of the chambers in the 
shuttle box consisted of stainless 
steel rods. This apparatus was for 
LHT.  
2. Polypropylene vessel 
(45x40x30cm) for FST, 3.Stop 
watch, 4. Pediatric nasogastric 
tube. 
Drugs: Pure powder form of the following 
drugs were obtained from different sources  
1. Imipramine (Torrent 
pharmaceuticals Ltd.) 
2. Ashwagandha and Bramhi (Indian 
Herbs research and supply co Ltd., 
Saharanpur, Uttarpradesh). 
 
Study Design: Experimental protocol was 
approved by Institutional Animal Ethics 
Committee before starting the study. 
Design of this study was comparative and 
parallel groups.  Animals were divided 
into 24 groups (12 groups for LHT & FST 
each) containing six rats in each group.  
 
Study Groups with drug administered and doses - 
Group Drugs & Doses 
(mg/kg) 
Group Drugs & Doses 
(mg/kg) 
Group Drugs & Doses 
(mg/kg) 
Group I Normal saline 
(5ml/kg) 
Group 
V 
Bramhi (20) Group 
IX 
Ashwagandha (100) 
Group 
II 
Imipramine (16) Group 
VI 
Bramhi (40) Group 
X 
Ashwagandha (150) 
Group Imipramine (32) Group Bramhi (80) Group Imipramine 
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III VII XI (16)+Bramhi (20) 
Group 
IV 
Imipramine (64) Group 
VIII 
Ashwagandha 
(50) 
Group 
XII 
Imipramine (16) 
+Ashwagandha (50) 
Following is the schedule for each group (n=6) receiving drug orally through pediatric 
nasogastric tube with mentioned dose in parenthesis for each test (LHT & FST). 
 
Normal saline as control, 
imipramine as standard, Ashwagandha & 
bramhi as test drugs were administered 
orally as per the study protocol. The doses 
of control, standard and the test drugs were 
selected after observing the response of 
pilot doses of each, calculated by 
considering their recommended dose for 
clinical use and on the basis of earlier 
studies available in literature 
respectively.(7) Freshly prepared 
suspension of the drugs with vehicle 
normal saline, was administered orally 
through a pediatric nasogastric tube 
followed by 5ml of distilled water. Each 
dose of individual and combinations drugs 
were given for 14 days, 1 hr before the 
experiment. Earlier studies (8-10) stated 
that repeated oral administration did not 
causes signs of intoxication.  
 
Learned Helplessness Test (5):  
In this test, an animal is initially 
exposed to uncontrollable stress 
(unavoidable response). When the animal 
is later placed in a situation in which shock 
is controllable (escapable), the animal not 
only fails to acquire the escape responses 
but also often makes no efforts to escape 
the shock at all. This escape deﬁcit is 
reversed by chronic antidepressant 
treatment.(11)(12) Learned helplessness 
behavioral tests were performed with the 
Gemini Avoidance System. This apparatus 
is divided into two equal compartments by 
a retractable door. Floors of the chambers 
in the shuttle box consisted of stainless 
steel rods. Scrambled shocks were 
delivered through a shock generator.  
The drugs were used at three dose 
levels. Low dose combination of 
imipramine, bramhi and ashwagandha was 
administered orally for 2wks, starting on 
day 1 , 60min before the inescapable 
shocks, and on day 12, the rats were 
individually placed in the chamber and 
given 90 inescapable shocks (0.8 mA) of 
15 s duration at 45sec intervals. Control 
rats were not given shocks. On day 14, the 
rats were subjected to the 30-trial escape 
test. The animals were individually placed 
in the shuttle box and given a 5-min 
adaptation period; a tone signal was given 
during the first 5sec of each trial 
(conditioned response). If there was no 
avoidance response within this period, the 
tone signal remained on and a 0.8mA 
shock (15sec duration) was delivered 
through the grid floor. If no escape 
response was made within this period, both 
the tone signal and the shock were 
automatically terminated. The intertrial 
interval was 5 s. The number of escape 
failures and avoidance response which 
refers to a noncrossing-crossing response 
during the shock delivery was recorded. 
 
Forced swimming Test (6):  
The test was based on the method 
described by Porsolt. Rats were made to 
swim individually in a polypropylene 
vessel (45x40x30cm) with a water level of 
20 cm height and maintain at a 
temperature 22± 1˚C, this ensued that the 
rats’ feet didn’t touch the floor of the 
vessel and that it could not climb out of it. 
The entire study was divided in to two 
sessions. 
A. Pretest session: Animals (rats) 
were forced to swim individually for 15 
minutes in the polypropylene container for 
14 days. 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
Tamoghna Maiti et.al, Evaluation of Antidepressant Effect of Ashwagandha and Brahmi 
 
43 
B.  Test session: 24 hours latter i.e. 
on 15
th
 day each animal was again forced 
to swim for a period of 6 minutes in a test 
session. Each animal made vigorous 
attempt to get out of the polypropylene 
container during the first couple of 
minutes and there after surrendered to 
experimental conditions and became 
immobile with occasional escape attempts 
(characterized by complete cessation of 
swimming with the head lifting just above 
the water level as noted).  This immobility 
period, after frenzied attempts to escape is 
postulated to represent the “Behavioural 
despair” in an animal experimental model. 
The total duration of immobility during 
last 4 minutes of a 6 minutes test was 
recorded as period of despair. 
 
Statistical Analysis  
Data were statistically analyzed by 
one way ANOVA followed by Dunnet’s t-
test. Results were expressed as mean 
number of each group + standard error of 
mean(SEM)[mean ± SEM].  ‘P’ value 
<0.05 was considered significant.   
 
Observation and results  
The results (Table 1& 2) showed 
significant increase in the number of rats 
showing avoidance response also 
reduction in the number of rats showing 
escape failure and immobility period. 
Avoidance response and escape failure in 
case of imipramine and ashwagandha 
showed highly significant result on 
individual use. But there was no 
significant result in case of all doses of 
bramhi except in case of escape failure and 
immobility period, bramhi in higher doses 
showed just significant result. In 
combination doses there was highly 
significant increase in the number of 
avoidance response also reduction in 
escape failure and in immobility period 
when compared to low doses of all drugs 
given alone.  
 
Discussion 
Ashwagandha an indigenous herbal 
product of Indian origin at the given dose 
levels produces significant reduction in 
both the parameters. The potency of 
Ashwagandha against depression in animal 
models was demonstrated earlier by 
Griebel et al(13) who compared the above 
indigenous herbal products with that of the 
standard SSRI. Bhattacharya SK & Goel 
RK also reported similar reduction in all 
the parameters which comparable to the 
present.  
Bramhi is famous for its memory 
enhancing tranquilizing and antioxidant 
properties.(14) Bramhi in low dose level, 
no significant reduction in any of the 
parameter were detected. This is 
comparable to that of Achiliya GS.(15) 
The positive effect of imipramine 
in the learned helplessness test and Forced 
swimming test model seems to be due to 
increased availability of these 
neurotransmitters norepinephrine (NE) and 
serotonin (5HT) at the post synaptic site 
following their reuptake inhibition. But 
uptake blocked is not directly responsible 
for antidepressant action. Thus it is 
attributed to these coronary events that 
followed the primary drugs on presynaptic 
α2, 5HT1a, 5HT1d auto receptors and 
amines turn over in brain. However, the 
antidepressant action of a drug is due to 
the respective synaptic sites in the brain 
region, net effect is enhancement of 
noradrenergic and serotonergic 
transmission.(16) 
Ashwagandha is an essential 
popular Indian medical plant with marked 
antiaging, immunomodulatory, anti 
anxiety and stress relieving property, acts 
by normalizing the augmented 
Lipoxygenese (LPO) activities and 
enhancing the activities Glutathione 
peroxidase (GPX).(17) From our study, we 
have seen that it has marked antidepressant 
effect and it also causes the enhancement 
of effect when combined with low dose of 
imipramine. This result corroborates with 
Bhattacharya SK.(18) Although it has 
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marked memory enhancing activity and 
antioxidant property but have very little 
antidepressant effect and our study also 
shows similar antidepressant effect when 
used alone. But potentiate the effect of 
imipramine when combine in low doses.  
 
Conclusion:  
The present study evaluated that 
Ashwagandha had significant 
antidepressant action but Bramhi had not 
when used alone. These two drug showed 
high efficacy in depression model when 
combine with low dose imipramine. So 
these drugs may be tried in the treatment 
of depression and further scientific 
research should be under taken towards 
this dimension. 
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Table 1:  Effect of Bramhi & Ashwagandha alone and in combination with 
imipramine on Avoidance response and Escape failure, using learned 
helplessness test model. 
Group 
Drugs 
(mg/kg,P.O) 
Number of 
Avoidance 
response  
[ mean   ± 
SEM] 
Increase 
of 
number 
of 
avoidance 
response 
(%) 
Number of 
Escape 
failure 
[ mean  ± 
SEM] 
Decrease 
of number 
of escape 
failure (%) 
I 
Normal saline (5 
ml/kg) 
13.33 ± 0.42 0 7.5 ± 0.43 0 
II Imipramine (16) 13.83 ± 0.60
 
3.75 6.33 ± 0.49 15.6 
III Imipramine (32) 17.67 ± 0.88
a 
32.56 3.83 ± 0.40
a 
48.93 
IV Imipramine (64) 20.33 ± 0.71
a 
52.51 3.17 ± 0.31
a 
57.73 
V Bramhi (20) 13.5 ± 0.43 1.27 6.33 ± 0.49
 
15.6 
VI Bramhi (40) 14 ± 0.58 5.03 6 ± 0.58
 
20 
VII Bramhi (80) 14.67 ± 0.49 10.05 5.83 ± 0.31
b 
22.27 
VIII Ashwagandha (50) 16.33 ± 0.42
a
 22.51 5.33 ± 0.33
a 
28.93 
IX 
Ashwagandha 
(100) 
16.83 ± 0.40
a 
26.26 4.33 ± 0.42
a 
42.27 
X 
Ashwagandha 
(150) 
19.17 ± 0.48
a 
43.81 3.66 ± 0.33
a 
51.2 
XI 
Imipramine (16) + 
Bramhi (20) 
16.33 ± 0.88
a 
22.51 4.33 ± 0.33
a 
42.27 
XII 
Imipramine (16)+ 
Ashwagandha (50) 
21 ± 0.47
a 
57.54 3 ± 0.36
a 
60 
One 
Way 
ANOVA 
 
Results are given as no of avoidance response mean ± SEM in learned 
helplessness test . a-p<0.001 ,b-p<0.01Vs simple control (NS) with shock. N=6 in 
each group. 
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Table 2:        Effect of Bramhi & Ashwagandha alone and in combination with 
imipramine on Immobility, using forced swimming test. 
Group Treatment (mg/kg, P.O) 
Duration of 
immobility mean 
(sec) ± SEM 
% Reduction of 
duration of 
immobility 
I Normal saline (5 ml/kg) 185.33 ± 0.08 0 
II Imipramine (16) 180.17 ± 0.91
 
2.78 
III Imipramine (32) 132 ± 1.03
a 
28.78 
IV Imipramine (64) 90 ± 1.03
a 
51.33 
V Bramhi(20) 184.83 ± 0.60 0.27 
VI Bramhi(40) 180 ±  0.37
 
2.88 
VII Bramhi(80) 179 ± 0.58
b 
3.44 
VIII Ashwagandha(50) 173.5  ± 2.88
a 
6.38 
IX Ashwagandha (100) 127.83 ± 1.66
a 
31.02 
X Ashwagandha (150) 70.17 ± 2.59
a 
62.13 
XI Imipramine (16)+ Bramhi (20) 120.33 ± 0.49
a 
35.07 
XII 
Imipramine (16)+ Ashwagandha 
(50) 
67.83 ± 2.64
a 
63.4 
One way 
ANOVA 
Results are given as mean duration of immobility ± SEM in last 4 min. of 6 min. 
test. a-p<0.001 Vs simple control, b-
 
p<0.01 Vs simple control (N.S.). 
 
***** 
